São Paulo - Delayed Quote BRL

HCA Healthcare, Inc. (H1CA34.SA)

Compare
91.89 +0.18 (+0.20%)
At close: June 21 at 3:29 PM GMT-3
Loading Chart for H1CA34.SA
DELL
  • Previous Close 91.71
  • Open 0.00
  • Bid 87.00 x --
  • Ask 92.52 x --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 94.78
  • Volume 0
  • Avg. Volume 770
  • Market Cap (intraday) 484.265B
  • Beta (5Y Monthly) 1.70
  • PE Ratio (TTM) 16.80
  • EPS (TTM) 5.47
  • Earnings Date Jul 25, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 0.47 (0.51%)
  • Ex-Dividend Date Jun 13, 2024
  • 1y Target Est --

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

www.hcahealthcare.com

220,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: H1CA34.SA

Performance Overview: H1CA34.SA

Trailing total returns as of 6/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

H1CA34.SA
40.93%
S&P 500
14.57%

1-Year Return

H1CA34.SA
34.22%
S&P 500
24.52%

3-Year Return

H1CA34.SA
82.31%
S&P 500
31.16%

5-Year Return

H1CA34.SA
184.33%
S&P 500
62.14%

Compare To: H1CA34.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: H1CA34.SA

Valuation Measures

Annual
As of 6/21/2024
  • Market Cap

    484.26B

  • Enterprise Value

    706.95B

  • Trailing P/E

    16.80

  • Forward P/E

    16.34

  • PEG Ratio (5yr expected)

    1.49

  • Price/Sales (ttm)

    1.38

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.94

  • Enterprise Value/EBITDA

    9.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.20%

  • Return on Assets (ttm)

    11.12%

  • Return on Equity (ttm)

    845.54%

  • Revenue (ttm)

    66.72B

  • Net Income Avi to Common (ttm)

    5.47B

  • Diluted EPS (ttm)

    5.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.38B

  • Total Debt/Equity (mrq)

    3,315.20%

  • Levered Free Cash Flow (ttm)

    3.78B

Research Analysis: H1CA34.SA

Company Insights: H1CA34.SA

Research Reports: H1CA34.SA

People Also Watch